Share-based Payment Arrangement, Expense of HilleVax, Inc. from 31 Dec 2021 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
HilleVax, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2021 to 30 Jun 2025.
  • HilleVax, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Jun 2025 was $2,330,000, a 62% decline year-over-year.
  • HilleVax, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Jun 2025 was $14,288,000, a 25% decline year-over-year.
  • HilleVax, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $20,784,000, a 53% increase from 2023.
  • HilleVax, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $13,590,000, a 353% increase from 2022.
  • HilleVax, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $3,003,000, a 4382% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

HilleVax, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $14,288,000 $2,330,000 -$3,731,000 -62% 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $18,019,000 $2,429,000 -$2,765,000 -53% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $20,784,000 $4,479,000 +$723,000 +19% 01 Oct 2024 31 Dec 2024 10-K 28 Mar 2025 2024 FY
Q3 2024 $20,061,000 $5,050,000 +$1,104,000 +28% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $18,957,000 $6,061,000 +$2,815,000 +87% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025 2025 Q2
Q1 2024 $16,142,000 $5,194,000 +$2,552,000 +97% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $13,590,000 $3,756,000 +$2,425,000 +182% 01 Oct 2023 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q3 2023 $11,165,000 $3,946,000 +$3,102,000 +368% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $8,063,000 $3,246,000 +$2,690,000 +484% 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2024 2024 Q2
Q1 2023 $5,373,000 $2,642,000 +$2,370,000 +871% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q3
Q4 2022 $3,003,000 $1,331,000 01 Oct 2022 31 Dec 2022 10-K 20 Mar 2024 2023 FY
Q3 2022 $844,000 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $556,000 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $272,000 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023 2023 Q1

HilleVax, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $20,784,000 +$7,194,000 +53% 01 Jan 2024 31 Dec 2024 10-K 28 Mar 2025 2024 FY
2023 $13,590,000 +$10,587,000 +353% 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2025 2024 FY
2022 $3,003,000 +$2,936,000 +4382% 01 Jan 2022 31 Dec 2022 10-K 20 Mar 2024 2023 FY
2021 $67,000 01 Jan 2021 31 Dec 2021 10-K 17 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.